Pair Name | Noscapine, Cisplatin | ||
Phytochemical Name | Noscapine (PubChem CID: 275196 ) | ||
Anticancer drug Name | Cisplatin (PubChem CID: 5702198 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Noscapine, Cisplatin | |||
Disease Info | [ICD-11: 2C73] | Ovarian cancer | Investigative | |
Biological Phenomena | Induction-->Blockade of cell cycle in G2/M phase | |||
Gene Regulation | Down-regulation | Expression | BIRC5 | hsa332 |
Up-regulation | Expression | CASP3 | hsa836 | |
Down-regulation | Expression | NFKB1 | hsa4790 | |
Down-regulation | Expression | XIAP | hsa331 | |
In Vitro Model | SK-OV-3/CDDP | Ovarian serous cystadenocarcinoma | Homo sapiens (Human) | CVCL_D622 |
In Vivo Model | SKOV3/DDP cells in the logarithmic growth stage were diluted to 3×10⁷/ml. Single cell suspension (0.2 ml/mouse) was subcutaneously injected into the right scapular region of nude mice. | |||
Result | Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways |
Pair Name | Noscapine, Cisplatin | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Up-regulation | Expression | BAX | hsa581 | |
Up-regulation | Expression | BCL2 | hsa596 | |
Down-regulation | Expression | BIRC5 | hsa332 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Cleavage | CASP8 | hsa841 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Up-regulation | Expression | CASP9 | hsa842 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Up-regulation | Expression | CDKN1A | hsa1026 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Up-regulation | Expression | TP53 | hsa7157 | |
In Vitro Model | NCI-H460 | Lung large cell carcinoma | Homo sapiens (Human) | CVCL_0459 |
A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 | |
In Vivo Model | For a xenograft model, 3×10⁶ H460 cells were injected subcutaneously into right flank area of mice. | |||
Result | Our results suggest that Nos enhanced the anticancer activity of Cis in an additive to synergistic manner by activating multiple signaling pathways including apoptosis. These findings suggest potential benefit for use of Nos and Cis combination in treatment of lung cancer. |
No. | Title | Href |
---|---|---|
1 | Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Cell Biochem Biophys. 2015 May;72(1):203-13. doi: 10.1007/s12013-014-0438-y. | Click |
2 | Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. Lung Cancer. 2011 Mar;71(3):271-82. doi: 10.1016/j.lungcan.2010.06.002. | Click |